Press Release – New York, NY – April 14, 2022 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: “RLMD”), a late-stage biotechnology company, in a …
Sichenzia Ross Ference LLP Represents Biotricity, Inc. in $50 Million At-The-Market Offering Facility
Press Release – New York, NY – March 23, 2022 – Sichenzia Ross Ference LLP announced today that it represented Biotricity, Inc. (NASDAQ: “BTCY”), a medical diagnostic and consumer healthcare …
Sichenzia Ross Ference LLP Represents AiAdvertising, Inc. in $10 Million Private Placement Offering
Press Release – New York, NY – March 28, 2022 – Sichenzia Ross Ference LLP today announced that it represented AiAdvertising, Inc., an innovative technology company and leading provider of AI-enabled …
Sichenzia Ross Ference LLP Represents Sharps Technology, Inc. in $16 Million Initial Public Offering
Press Release – New York, NY – April 19, 2022 – Sichenzia Ross Ference LLP announced today that it represented Sharps Technology, Inc. (Nasdaq: STSS and STSSW), an innovative medical device company …
Sichenzia Ross Ference LLP Represents Boustead Securities LLC in $22.5 Million Underwritten Public Offering for Genius Group Limited.
Press Release – New York, NY –April 15, 2022 – Sichenzia Ross Ference LLP congratulates Genius Group Limited (“Genius Group” or the “Company”) (NYSE: GNS), a world-leading entrepreneur Edtech and …
CMF Represents EF Hutton In $5.7 Million Underwritten Public Offering Of Statera Biopharma, Inc.
FORT COLLINS, Colo., March 24, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a leading biopharmaceutical company creating next-generation …
